StockSelector.com
  Research, Select, & Monitor Sunday, June 16, 2019 6:31:06 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Corbus Pharmaceuticals Holdings, Inc.$6.85($.25)(3.52%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Corbus Pharmaceuticals Holdings, Inc. has an overall rank of 6713 out of 6935 stocks based on 4 positive rankings and 10 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $28.00 for Corbus Pharmaceuticals Holdings using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Corbus Pharmaceuticals Holdings is ranked 13.
Estimated Revenue Growth
Corbus Pharmaceuticals Holdings rank is 280
Low Put/Call
Corbus Pharmaceuticals Holdings has a low Put/Call ratio of 0.30 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Corbus Pharmaceuticals Holdings is ranked 721.
Debt-to-Equity
Corbus Pharmaceuticals Holdings rank is 1467
Negative Rankings
Price-to-Sales
Corbus Pharmaceuticals Holdings rank is 140
Negative Net Margin
Corbus Pharmaceuticals Holdings rank is 168
Negative ROE
Corbus Pharmaceuticals Holdings rank is 175
Negative ROA
Corbus Pharmaceuticals Holdings rank is 214
Price-to-Book
Corbus Pharmaceuticals Holdings rank is 282
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Corbus Pharmaceuticals Holdings is ranked 415.
10 Day Loss
Corbus Pharmaceuticals Holdings rank is 855
90 Day Loss
Corbus Pharmaceuticals Holdings rank is 1171
High vPut/Call
Corbus Pharmaceuticals Holdings has a high Put/Call ratio of 0.91 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Corbus Pharmaceuticals Holdings is ranked 1418.
Down EPS Surprise
Corbus Pharmaceuticals Holdings missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.